BrittMeredith(Holderness)OlmstedMD

PubMed

• 28 citations
  Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival.
  Shaofeng Yan, Britt M. Holderness, Zhongze Li, Gregory D. Seidel, Jiang Gui, Jan L. Fisher, Marc S. Ernstoff> ;Anticancer Research. 2016 Dec 1
• 6 citations
  Thromboprophylaxis and Outcomes for Total Joint Arthroplasty in Congenital Bleeding Disorders A Single-Center Experience
  Britt M. Holderness, Yuika Goto, Laurel Mckernan, Philip M. Bernini, Deborah L. Ornstein> ;Clinical and Applied Thrombosis/hemostasis. 2016 Apr 20
• 66 citations
  Implementation of a Molecular Tumor Board: The Impact on Treatment Decisions for 35 Patients Evaluated at Dartmouth-Hitchcock Medical Center
  Laura J. Tafe, Ivan P. Gorlov, Francine B. de Abreu, Joel A. Lefferts, Xiaoying Liu, Jason R. Pettus, Jonathan D. Marotti, Kasia J. Bloch, Vincent A. Memoli, Arief A. ...> ;The Oncologist. 2015 Sep 1
• 31 citations
  Brentuximab vedotin demonstrates activity in a patient with plasmablastic lymphoma arising from a background of chronic lymphocytic leukemia.
  Holderness, B. M., Malhotra, S., Levy, N. B., Danilov, A. V.> ;Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Apr 20
• Join now to see all